Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients with Ulcerative Colitis.

William J Sandborn,Laurent Peyrin-Biroulet,Jinkun Zhang,Michael Chiorean,Séverine Vermeire,Scott D Lee,Tanja Kühbacher,Bruce Yacyshyn,Christopher H Cabell,Snehal U Naik,Preston Klassen,Julián Panés

Gastroenterology（2020）

Cited 154|Views24
No score
Abstract
In patients with moderately to severely active UC, etrasimod 2 mg was more effective than placebo in producing clinical and endoscopic improvements. Further clinical development is warranted. Clinicaltrials.gov no: NCT02447302.
More
Translated text
Key words
Immunomodulatory Therapy,Inflammatory Bowel Disease,S1P Receptor Modulator,Ulcerative Colitis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined